stockrowAmphastar Pharmaceuticals, Inc. (AMPH) vs Harrow, Inc. (HROW)
- Amphastar Pharmaceuticals, Inc. AMPH 27.59 −1.53%
- Harrow, Inc. HROW 26.05 −9.39%
Amphastar Pharmaceuticals, Inc. and Harrow, Inc. are both Drug Manufacturers Specialty & Generic companies. Amphastar Pharmaceuticals, Inc. is the larger, with a market value of $1.2B against $976.2M — 1.2× the size. Harrow, Inc. has negative trailing earnings, so its P/E is not meaningful; Amphastar Pharmaceuticals, Inc. trades at 12.3×. Harrow, Inc. grew revenue faster over the last twelve months: 21.1% against 3.11%. Amphastar Pharmaceuticals, Inc. has the higher net margin (13.3% vs −13.5%) and the higher return on invested capital (6.12% vs −0.77%). Across the 20 metrics below, Amphastar Pharmaceuticals, Inc. leads on 16 and Harrow, Inc. on 4.
Valuation
Profitability
| Metric | AMPH | HROW | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 46.81% | 73.28% | 53.51% |
| Operating margin | 18.74% | (1.00%) | 0.00% |
| Net margin | 13.27% | (13.51%) | (2.45%) |
| Free cash flow margin | 18.64% | (4.75%) | 0.00% |
| Return on equity | 12.44% | (116.07%) | (0.80%) |
| Return on assets | 5.86% | (9.77%) | (1.67%) |
| Return on invested capital | 6.12% | (0.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack